Combining in silico and biophysical methods for the development of Pseudomonas aeruginosa quorum sensing inhibitors: an alternative approach for structure-based drug design.
暂无分享,去创建一个
Rolf Müller | Rolf W Hartmann | Michael P. Storz | R. Hartmann | R. Müller | Christian Brengel | A. Plaza | Matthias F. Groh | J Henning Sahner | Christian Brengel | Michael P Storz | Matthias Groh | Alberto Plaza | J. H. Sahner
[1] Timothy F. Havel,et al. NMR structure determination in solution: a critique and comparison with X-ray crystallography. , 1992, Annual review of biophysics and biomolecular structure.
[2] L. Rahme,et al. MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR‐class regulatory protein, has dual ligands , 2006, Molecular microbiology.
[3] M. Negri,et al. Novel small molecule inhibitors targeting the "switch region" of bacterial RNAP: structure-based optimization of a virtual screening hit. , 2013, European journal of medicinal chemistry.
[4] M. Negri,et al. Influence of DNA Template Choice on Transcription and Inhibition of Escherichia coli RNA Polymerase , 2012, Antimicrobial Agents and Chemotherapy.
[5] R. Copeland,et al. Drug–target residence time and its implications for lead optimization , 2007, Nature Reviews Drug Discovery.
[6] A. Limaye,et al. Invasive Pseudomonas aeruginosa infections: high rate of recurrence and mortality after hematopoietic cell transplantation , 2007, Bone Marrow Transplantation.
[7] R. Hartmann,et al. Biosynthesis of 2‐Alkyl‐4(1H)‐Quinolones in Pseudomonas aeruginosa: Potential for Therapeutic Interference with Pathogenicity , 2011, Chembiochem : a European journal of chemical biology.
[8] Jonas Boström,et al. Reproducing the conformations of protein-bound ligands: A critical evaluation of several popular conformational searching tools , 2001, J. Comput. Aided Mol. Des..
[9] S. Rault,et al. Thiaisatoic anhydrides: Efficient synthesis under microwave heating conditions and study of their reactivity , 1998 .
[10] Arthur J. Olson,et al. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..
[11] Gerard J Kleywegt,et al. Application and limitations of X-ray crystallographic data in structure-based ligand and drug design. , 2003, Angewandte Chemie.
[12] S. Rault,et al. Synthesis and combinatorial approach of the reactivity of 6- and 7-arylthieno[3,2-d][1,3]oxazine-2,4-diones , 2003 .
[13] Michael P. Storz,et al. Validation of PqsD as an anti-biofilm target in Pseudomonas aeruginosa by development of small-molecule inhibitors. , 2012, Journal of the American Chemical Society.
[14] M. Hentzer,et al. Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections. , 2003, The Journal of clinical investigation.
[15] H. Moser,et al. Physicochemical properties of antibacterial compounds: implications for drug discovery. , 2008, Journal of medicinal chemistry.
[16] A. Prince,et al. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. , 2007, Current opinion in pharmacology.
[17] S. Diggle,et al. Quorum sensing by 2-alkyl-4-quinolones in Pseudomonas aeruginosa and other bacterial species. , 2008, Molecular bioSystems.
[18] Bernd Meyer,et al. Characterization of Ligand Binding by Saturation Transfer Difference NMR Spectroscopy. , 1999, Angewandte Chemie.
[19] E. Eisenstein,et al. Structure of PqsD, a Pseudomonas quinolone signal biosynthetic enzyme, in complex with anthranilate. , 2009, Biochemistry.
[20] J. Taunton,et al. Irreversible Nek2 kinase inhibitors with cellular activity. , 2011, Journal of medicinal chemistry.